Boston Scientific (BSX) Net Cash Flow (QoQ) (2009 - 2026)
Boston Scientific (BSX) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -77.34% |
| Mar 31, 2026 | -175.30% |
| Dec 31, 2025 | -9.36% |
| Sep 30, 2025 | 509.44% |
| Jun 30, 2025 | -165.69% |
| Mar 31, 2025 | 113.47% |
| Dec 31, 2024 | -386.60% |
| Sep 30, 2024 | -173.85% |
| Jun 30, 2024 | -60.91% |
| Mar 31, 2024 | 1,887.65% |
| Dec 31, 2023 | -115.67% |
| Sep 30, 2023 | 471.94% |
| Jun 30, 2023 | 61.71% |
| Mar 31, 2023 | -158.08% |
| Dec 31, 2022 | 1,258.70% |
| Sep 30, 2022 | 169.70% |
| Jun 30, 2022 | 95.97% |
| Mar 31, 2022 | -18,300.00% |
| Dec 31, 2021 | 101.22% |
| Sep 30, 2021 | -214.11% |